YZi Labs: Condemns CEA Industries' board of directors for using a poison pill plan and stripping shareholders of their rights.

[YZi Labs Condemns CEA Industries Board's Poison Pill Plan and Deprivation of Shareholder Rights] According to official sources, YZi Labs is reviewing CEA Industries' response to YZi Labs' written consent solicitation process. These actions include employing a poison pill plan and amending the company's bylaws, aimed at thwarting and delaying shareholders' exercise of their rights. YZi Labs believes the board's aim is to consolidate its own position and has already postponed its 2025 annual meeting until after the anniversary on December 17th. Furthermore, YZi Labs refutes CEA Industries' statement that it has never considered alternative token strategies, pointing out that CEO David Namdar clearly stated at an industry conference in November 2025 that they were considering switching to assets such as Solana. YZi Labs urges the board to refrain from further actions and ensure a fair nomination and election process for directors.